Business Context and Reporting Period
This Form 8-K reports on the 2015 Annual General Meeting of Shareholders held by Stellar Biotechnologies, Inc. on February 12, 2015. The registrant is incorporated in British Columbia, Canada, with principal executive offices in Port Hueneme, California. Note: The request metadata references "Edesa Biotech, Inc.," but the filing text explicitly identifies the registrant as Stellar Biotechnologies, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholders voted on two primary matters:
- Election of Directors: Six nominees were elected to serve until the 2016 annual meeting. All nominees received significant support, with votes "for" ranging from approximately 9.76 million to 9.79 million. Votes withheld ranged from approximately 1.37 million to 1.40 million per nominee. Broker non-votes were approximately 25.15 million for each nominee.
- Appointment of Auditors: Shareholders approved the appointment of Moss Adams LLP as the independent registered public accounting firm. The vote was 33,172,037 "for" and 3,140,240 "withheld," with zero broker non-votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the correct registrant name (Stellar Biotechnologies, Inc.) versus the metadata reference (Edesa Biotech, Inc.).
- Confirm the tenure of the newly elected directors (Frank R. Oakes, David L. Hill, Mayank Sampat, Daniel E. Morse, Gregory T. Baxter, Tessie M. Che).
- Review the engagement letter or subsequent filings regarding the appointment of Moss Adams LLP as the new auditor.
- Assess the high volume of broker non-votes (~25 million) relative to the total votes cast for director elections.